UK markets closed

ImmuPharma plc (IMM.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1.7750+0.0025 (+0.14%)
At close: 04:13PM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-2,922
-2,922
-3,807
-8,174
-6,860
-
Depreciation & amortisation
37.607
37.607
117.563
114.119
170.954
-
Stock-based compensation
140.238
140.238
159.874
616.423
1,578
-
Change in working capital
469.601
469.601
-428.776
631.597
105.546
-
Other working capital
-1,364
-1,364
-2,453
-4,884
-3,690
-
Net cash provided by operating activities
-1,364
-1,364
-2,347
-4,833
-3,329
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-106.009
-50.934
-360.29
-107.111
Purchases of investments
0
-
-
0
-250
0
Net cash used for investing activities
188.762
188.762
-77.424
-50.283
-569.201
-
Net change in cash
-453.549
-453.549
-876.759
-4,181
4,472
-
Cash at beginning of period
667.813
667.813
1,649
5,862
1,365
-
Cash at end of period
208.481
208.481
667.813
1,649
5,862
-
Free cash flow
Operating cash flow
-1,364
-1,364
-2,347
-4,833
-3,329
-
Capital expenditure
-
-
-106.009
-50.934
-360.29
-107.111
Free cash flow
-1,364
-1,364
-2,453
-4,884
-3,690
-